Malignant Solid Tumors: GEN1057 Treatment

We are assessing the safety and potential effectiveness of GEN1057 for individuals with malignant solid tumors. This trial aims to see how well it works compared to current treatments.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Hospital Universitari Vall D Hebron
Medical Oncology
Barcelona, Spain
Hospital Universitario Hm Sanchinarro
Oncology Phase I trials unit
Chamartín, Spain
Sponsor: Genmab A/S
Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.